Amylyx Pharmaceuticals to Participate in the Evercore ISI 5th Annual HealthCONx Conference
23 November 2022 - 1:00AM
Business Wire
Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) today announced that
Joshua Cohen and Justin Klee, Co-CEOs of Amylyx, will participate
in the Evercore ISI 5th Annual HealthCONx Conference. The
conference is being conducted in a virtual format, and the fireside
chat will take place on Tuesday, November 29, 2022 at 3:05 p.m.
ET.
A live webcast of the fireside chat can be accessed under
“Events” in the Investor section of the Company’s website,
https://investors.amylyx.com/news-events/events, and will be
available for replay for 90 days following the event.
About Amylyx Pharmaceuticals
Amylyx Pharmaceuticals, Inc. is committed to supporting and
creating more moments for the neurodegenerative community through
the discovery and development of innovative new treatments. Amylyx
is headquartered in Cambridge, Massachusetts and has operations in
Canada and EMEA. For more information, visit amylyx.com and follow
us on LinkedIn and Twitter. For investors, please visit
investors.amylyx.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20221122005013/en/
Media Becky Gohsler Finn Partners (646) 307-6307
Becky.Gohsler@finnpartners.com Investors Lindsey Allen
Amylyx Pharmaceuticals, Inc. (857) 320-6244
Investors@amylyx.com
Amylyx Pharmaceuticals (NASDAQ:AMLX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Amylyx Pharmaceuticals (NASDAQ:AMLX)
Historical Stock Chart
From Apr 2023 to Apr 2024